Repeated 0.5-Gy γ irradiation attenuates experimental autoimmune encephalomyelitis with up-regulation of regulatory T cells and suppression of IL17 production

Radiation Research

Volumn 170, Issue 4, 2008, Pages 429-436

  Tsukimoto, Mitsutoshi ^a   Nakatsukasa, Hiroko ^a   Sugawara, Keigo ^a   Yamashita, Keiichiro ^a   Kojima, Shuji ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GAMMA IRRADIATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GAMMA RAYS; IMMUNIZATION; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; MYELIN BASIC PROTEINS; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

MUS; RODENTIA;

EID: 55249119122     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1352.1     Document Type: Article

References (42)

1. J. D. Lutton, R. Winston and T. C. Rodman, Multiple sclerosis: etiological mechanisms and future directions. Exp. Biol. Med. (Maywood) 229, 12-20 (2004).
2. B. Popko and K. D. Baerwald, Oligodendroglial response to the immune cytokine interferon gamma. Neurochem. Res. 24, 331-338 (1999).
3. H. Korner and J. D. Sedgwick, Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity. Immunol. Cell. Biol. 74, 465-472 (1996).
4. K. Selmaj, C. S. Raine and A. H. Cross, Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30, 694-700 (1991).
5. Z. Stelmasiak, M. Koziol-Montewka, B. Dobosz and K. Rejdak, IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients. Med. Sci. Monit. 7, 914-918 (2001).
6. T. Kishimoto, The biology of interleukin-6. Blood 74, 1-10 (1989).
7. Y. Okuda, S. Sakoda, C. C. Bernard, H. Fujimura, Y. Saeki, T. Kishimoto and T. Yanagihara, IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10, 703-708 (1998).
8. I. Mendel, N. Kerlero de Rosbo and A. Ben-Nun, A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25, 1951-1959 (1995).
9. S. S. Zamvil, D. J. Mitchell, A. C. Moore, K. Kitamura, L. Steinman and J. B. Rothbard, T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324, 258-260 (1986).
10. R. A. Sobel, J. M. Greer and V. K. Kuchroo, Minireview: autoimmune responses to myelin proteolipid protein. Neurochem. Res. 19, 915-921 (1994).
11. M. C. Dal Canto, R. W. Melvold, B. S. Kim and S. D. Miller, Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc. Res. Tech. 32, 215-229 (1995).
12. H. G. Bouwer, G. N. Dietsch and D. J. Hinrichs, Adoptive transfer of experimental allergic encephalomyelitis: conditions influencing memory and effector cell development. Cell. Immunol. 131, 219-231 (1990).
13. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34-38 (1995).
14. M. S. Horwitz, C. F. Evans, D. B. McGavern, M. Rodriguez and M. B. Oldstone, Primary demyelination in transgenic mice expressing interferon-gamma. Nat. Med. 3, 1037-1041 (1997).
15. + T helper cells. Cell 126, 1121-1133 (2006).
16. Y. Qian, C. Liu, J. Hartupee, C. Z. Altuntas, M. F. Gulen, D. Jane-Wit, J. Xiao, Y. Lu, N. Giltiay and X. Li, The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8, 247-256 (2007).
17. C. L. Roark, J. D. French, M. A. Taylor, A. M. Bendele, W. K. Born and R. L. O'Brien, Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells. J. Immunol. 179, 5576-5583 (2007).
18. C. Lock, G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella and L. Steinman, Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500-508 (2002).
19. Y. Komiyama, S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo and Y. Iwakura, IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566-573 (2006).
20. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193, 1311-1318 (2001).
21. A. Mimran and I. R. Cohen, Regulatory T cells in autoimmune diseases: anti-ergotypic T cells. Int. Rev. Immunol. 24, 159-179 (2005).
22. + regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res. Ther. 7, R402-R415 (2005).
23. + regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 175, 5591-5595 (2005).
24. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
25. S. Okajima, M. Mine and T. Nakamura, Mortality of registered A-bomb survivors in Nagasaki, Japan, 1970-1984. Radiat. Res. 103, 419-431 (1985).
26. R. N. Shen, L. Lu, H. E. Kaiser and H. E. Broxmeyer, Murine AIDS cured by low dosage total body irradiation. Adv. Exp. Med. Biol. 407, 451-458 (1997).
27. S. Kojima, K. Nakayama and H. Ishida, Low dose gamma-rays activate immune functions via induction of glutathione and delay tumor growth. J. Radiat. Res. (Tokyo) 45, 33-39 (2004).
28. S. Kojima, H. Shimomura and S. Matsumori, Effect of pre-irradiation with low-dose gamma-rays on chemically induced hepatotoxicity and glutathione depletion. Anticancer Res. 20, 1583-1588 (2000).
29. M. Takahashi, S. Kojima, K. Yamaoka and E. Niki, Prevention of type I diabetes by low-dose gamma irradiation in NOD mice. Radiat. Res. 154, 680-685 (2000).
30. T. Tanaka, F. Tago, S. P. Fang, N. Shimura and S. Kojima, Repeated 0.5-Gy gamma-ray irradiation attenuates autoimmune manifestations in MRL-lpr/lpr mice. Int. J. Radiat. Biol. 81, 731-740 (2005).
31. + regulatory T cells. Radiat. Res. 169, 59-66 (2008).
32. T. Shirakawa, T. Enomoto, S. Shimazu and J. M. Hopkin, The inverse association between tuberculin responses and atopic disorder. Science 275, 77-79 (1997).
33. T. Nishimura and A. Ohta, A critical role for antigen-specific Th1 cells in acute liver injury in mice. J. Immunol. 162, 6503-6509 (1999).
34. M. S. Horwitz, C. F. Evans, D. B. McGavern, M. Rodriguez and M. B. Oldstone, Primary demyelination in transgenic mice expressing interferon-gamma. Nat. Med. 3, 1037-1041 (1997).
35. H. Villarroya, Y. Marie, J. C. Ouallet, F. Le Saux, J. L. Tchelingerian and N. Baumann, Expression of TNF alpha in central neurons of Lewis rat spinal cord after EAE induction. J. Neurosci. Res. 49, 592-599 (1997).
36. E. C. Alvord, Jr., S. Hruby, C. M. Shaw and J. Slimp, Myelin basic protein and its antibodies in the cerebrospinal fluid in experimental allergic encephalomyelitis, multiple sclerosis and other diseases. Prog. Clin. Biol. Res. 146, 359-363 (1984).
37. E. B. Samoilova, J. L. Horton, B. Hilliard, T. S. Liu and Y. Chen, IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161, 6480-6486 (1998).
38. I. A. Ferber, S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton and C. G. Fathman, Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5-7 (1996).
39. R. R. Caspi, C. C. Chan, B. G. Grubbs, P. B. Silver, B. Wiggert, C. F. Parsa, S. Bahmanyar, A. Billiau and H. Heremans, Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. J. Immunol. 152, 890-899 (1994).
40. L. S. Jones, L. V. Rizzo, R. K. Agarwal, T. K. Tarrant, C. C. Chan, B. Wiggert and R. R. Caspi, IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol. 158, 5997-6005 (1997).
41. G. Matsuzaki and M. Umemura, Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol. Immunol. 51, 1139-1147 (2007).
42. E. Bettelli, Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner and V. K. Kuchroo, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006).